Fig. 8. A schematic illustration showed the therapeutic potential of Atractylodes lancea and its principal constituent, atractylodin, in addressing metabolic dysfunction-associated steatotic liver disease (MASLD). Atractylodes lancea and atractylodin exert significant benefits by activating the AMP-activated protein kinase (AMPK) signaling pathway. These interventions lead to improvements in high-fat-diet-induced obesity, fatty liver, and insulin resistance.
© Biomolecules & Therapeutics
